PPIG and cancer: Since CYP isoenzymes in particular play a critical role in the metabolism of a large number of anti-cancer drugs currently used for chemotherapy (e.g. taxanes, cyclophosphamide, doxorubicin and vinblastine) [4] it is likely that no clinically important interactions are to be expected for Helixor® A, M and P in vivo under therapeutic conditions.